The 4YFN “Powering Startups,” a parallel event to the Mobile World Congress 2025 and a key reference in the international entrepreneurial ecosystem, welcomes Kriba in this edition, which will take place from March 3 to 6.
Kriba will be present at a shared stand with Catalonia Health, where we will showcase our three applications: Kriba Newborn, Kriba Kidney, and Kriba Eye Care, along with a demonstration of the Neosonics® and Neosonics® Vitro Kidney devices.
Attendees will have the opportunity to interactively experience the operation of Neosonics, a non-invasive device that combines high-resolution ultrasound and AI algorithms for fast, simple, and cost-efficient screening and monitoring of extravascular infections in potentially life-threatening serous fluids, such as infant meningitis, peritoneal dialysis-associated peritonitis, and anterior uveitis, among others.
During the event, we will have the privilege of presenting our development progress and future plans, focused on obtaining the CE marking for Neosonics® Vitro Kidney. The goal of Kriba Kidney is to improve the early detection of peritoneal dialysis-associated peritonitis, which is crucial for reducing complications and preserving the quality of life of people undergoing peritoneal dialysis.
We appreciate Catalonia Health for the opportunity to participate in 4YFN 2025 within the Digital Health Pavilion, at Hall 8.0, stand 8.0B12. The stand will be divided into three areas. Kriba will be present in the diagnostics area alongside Qrem and Perdigó, the hospital area with Neuroelectrics, Bettercare, and Mycaretech, and a space for virtual reality technologies with VRAIn and WIVI vision.
Are you attending and want to schedule a meeting? Write to us at info@kriba.ai.
Neosonics® and Neosonics© Vitro Kidney are in the development phase. They are not for sale. This device has not yet been approved by the FDA or CE marking authorities.
